Journal profile · ONCOLOGY
Journal of Bone Oncology
ISSN 2212-1366 · eISSN 2212-1374 · Elsevier GmbH · NETHERLANDS
Journal of Bone Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.66; fully open access; APC about USD 2,990; median 68 days to acceptance (99 articles, last 24 months); 76 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Bone Oncology is published by Elsevier GmbH and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone health and treatments, Management of metastatic bone disease and Sarcoma Diagnosis and Treatment, together about 44.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Bone Oncology is an open access journal and is indexed in Clarivate Analytics' Journal Citation Reports/Science Edition as well as PubMedCentralThe Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.The areas covered by the journal include:Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)Preclinical models of metastasisBone microenvironment in cancer (stem cell, bone cell and cancer interactions)Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)Bone imaging (clinical and animal, skeletal interventional radiology)Bone biomarkers (clinical and translational applications)Radiotherapy and radio-isotopesSkeletal complicationsBone pain (mechanisms and management)Orthopaedic cancer surgeryPrimary bone tumoursClinical guidelinesMultidisciplinary careKeywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Robert ColemanPublisher website
Editorial board by country: 3 in mainland China (about 5%); most named United States 16, United Kingdom 9, France 7, Australia 7, Germany 6 (65 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone health and treatmentsMedicine17.7%
- Management of metastatic bone diseaseMedicine13.7%
- Sarcoma Diagnosis and TreatmentMedicine13.1%
- Bone Tumor Diagnosis and TreatmentsMedicine8.3%
- Cancer Diagnosis and TreatmentMedicine4.4%
- Bone Metabolism and DiseasesBiochemistry, Genetics and Molecular Biology3%
- Medical Imaging Techniques and ApplicationsMedicine2.9%
- Prostate Cancer Treatment and ResearchMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Journal Citation Reports/Science Edition
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.66LetPub ·
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- CiteScore (publisher)
- 5.8Publisher website ·
- SJR 2026-06
- 1.09LetPub ·
- SNIP 2026-06
- 1.31LetPub ·
- h-index
- 15LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 382OpenAlex ·
- 2-year mean citedness
- 3.39OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 76LetPub ·
Articles by year OpenAlex count · 839 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 68 | 68 | 19 |
| 2025 | 76 | 76 | 261 |
| 2024 | 135 | 135 | 667 |
| 2023 | 51 | 51 | 664 |
| 2022 | 54 | 54 | 988 |
| 2021 | 62 | 62 | 1,241 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
68 daysMedian, submission to acceptance · P25–P75 53 days – 99 days
- Acceptance to online
- median 5 days (99 articles)
- Submission to online
- median 73 days
- Sample
- 99 articles with submission and acceptance dates (160 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 20 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 37 daysPublisher website ·
- Submission to acceptance
- 70 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,990 / EUR 2,800 / GBP 2,390 / JPY 370,850 | — | — | |
| LetPub | USD 2,320 | Yes | — | |
| Publisher website | USD 3,580 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare10 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted10, with length limits
- case reportSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- commentaryCommentary Commentaries are commissioned by the Editor-in-Chief.Length not stated
- literature reviewSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- meta-analysisSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…main text ≤ 3,000 words · figures and tables ≤ 2 · references ≤ 10
- original research articleSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- perspectiveSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- protocolSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- reviewSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- review articleSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…Length not stated
- systematic reviewSubmissions covering the research areas mentioned under the section "Aims & Scope" are welcome for publication.Original Research Article Reports of original stu…main text ≤ 300 words · abstract ≤ 300 words · figures and tables ≤ 8 · references ≤ 150
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
1 to 7 keywords required Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier GmbH
- Country or region
- NETHERLANDS
- Language
- English
- ISSN
- 2212-1366
- Electronic ISSN
- 2212-1374
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Bone Oncology
What CAS zone is Journal of Bone Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Bone Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Bone Oncology?
The latest impact factor listed by LetPub is 3.66; CiteScore 5.8, h-index 53.
How long does peer review take at Journal of Bone Oncology?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 53–99 days); authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Bone Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Bone Oncology based?
Of the 65 board members whose country the journal's board page names, 3 (about 5%) are in mainland China; the countries named most often are United States (16), United Kingdom (9) and France (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Bone Oncology?
According to LetPub and DOAJ records, Journal of Bone Oncology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Journal of Bone Oncology open access, and what is the APC?
Journal of Bone Oncology is a fully open-access journal. APC about USD 2,990.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .